FindTrial
Sign In

Vibration positive expiratory pressure therapy in the perioperative period for esophageal cancer

Trial to evaluate the efficacy of vibration positive expiratory pressure therapy in the perioperative period for esophageal cancer - CCOG2302

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1042230119
Enrollment
50
Registered
2023-12-21
Start date
2023-12-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal carcinoma Esophageal carcinoma

Interventions

Vibration positive expiratory pressure therapy in the perioperative period for esophageal cancer
Vibration positive expiratory pressure therapy

Sponsors

Kanda Mitsuro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients scheduled for minimally invasive esophagectomy for curatively resectable esophageal cancer Patients with an ECOG performance status (PS) of 0, 1, or 2 Cases in which the patient's written consent has been obtained

Exclusion criteria

Exclusion criteria: Cases in which split surgery is performed Tracheostomies and cases with permanent tracheal holes Cases of emergency surgery Cases with a history of thoracic radiotherapy Cases with severe lung diseases (interstitial pneumonia, pulmonary fibrosis, severe emphysema, etc.) Patients with a history of clinically problematic mental disorders or central nervous system disorders Cases in which spirometry is not feasible. Patients with a history of pneumothorax Cases in which the principal investigator or physician in charge judges that the patient is not suitable to participate in this study

Design outcomes

Primary

MeasureTime frame
Percentage of pneumonia or atelectasis of grade II or higher of the Clavien-Dindo classification occurring by postoperative day 16—

Secondary

MeasureTime frame
Postoperative pneumonia rate (all grades of Clavien-Dindo classification and at least 2 points of The Utrecht Pneumonia scoring system by Karin Valkenet et al.) postoperative atelectasis rate (all grades of Clavien-Dindo classification) percentage of cricothyroid punctures Respiratory function tests Acapella Choice usage arterial blood gas analysis Serum sialylated carbohydrate antigen KL-6 perioperative antibiotic use (total number of days used postoperatively, including prophylactic antibiotics) duration of expectorant use independent scoring for pneumonia days on oxygen (total number of days on oxygen) grip strength, Short Physical Performance Battery—

Contacts

Public ContactDai Shimizu

Nagoya University Graduate School of Medicine

d-shimizu@med.nagoya-u.ac.jp+81-527442249

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026